ROLPH TIMOTHY (Chief Scientific Officer) reported 1 transaction at AKERO THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/19/2025ACC: 0001193125-25-288555
Officer· Chief Scientific Officer
Since Jun 2019
-37.10K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
37.10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−37.10K
Price / share
—
Trade value
—
% of position
22.3%
11/17/2025
166.57K→129.47K
Total
Net shares
−37.10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2025 | G · Gift | −37.10K | — | — | 22.3% | 166.57K | 129.47K |
| Total | −37.10K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported